- Home
- AZTA vs SRPT Comparison
AZTA vs SRPT Comparison
Compare AZTA & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTA
- SRPT
- Stock Information
- Founded
- AZTA 1978
- SRPT 1980
- Country
- AZTA United States
- SRPT United States
- Employees
- AZTA N/A
- SRPT N/A
- Industry
- AZTA Industrial Machinery/Components
- SRPT Biotechnology: Pharmaceutical Preparations
- Sector
- AZTA Technology
- SRPT Health Care
- Exchange
- AZTA Nasdaq
- SRPT Nasdaq
- Market Cap
- AZTA 1.4B
- SRPT 1.7B
- IPO Year
- AZTA 1995
- SRPT 1997
- Fundamental
- Price
- AZTA $34.43
- SRPT $11.93
- Analyst Decision
- AZTA Buy
- SRPT Hold
- Analyst Count
- AZTA 3
- SRPT 28
- Target Price
- AZTA $45.00
- SRPT $48.42
- AVG Volume (30 Days)
- AZTA 954.7K
- SRPT 13.9M
- Earning Date
- AZTA 08-05-2025
- SRPT 08-06-2025
- Dividend Yield
- AZTA N/A
- SRPT N/A
- EPS Growth
- AZTA N/A
- SRPT N/A
- EPS
- AZTA N/A
- SRPT N/A
- Revenue
- AZTA $669,171,000.00
- SRPT $2,233,371,000.00
- Revenue This Year
- AZTA N/A
- SRPT $19.93
- Revenue Next Year
- AZTA $4.88
- SRPT N/A
- P/E Ratio
- AZTA N/A
- SRPT N/A
- Revenue Growth
- AZTA 8.56
- SRPT 59.15
- 52 Week Low
- AZTA $23.91
- SRPT $10.42
- 52 Week High
- AZTA $63.58
- SRPT $150.48
- Technical
- Relative Strength Index (RSI)
- AZTA 62.82
- SRPT 28.15
- Support Level
- AZTA $31.27
- SRPT $10.42
- Resistance Level
- AZTA $35.33
- SRPT $14.54
- Average True Range (ATR)
- AZTA 1.60
- SRPT 1.90
- MACD
- AZTA 0.08
- SRPT 0.13
- Stochastic Oscillator
- AZTA 79.87
- SRPT 12.14
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.
About SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.